BEBOV GP Protein (AA 33-304) (His tag)

N° du produit ABIN6941976

Détail du produit

Antigène: BEBOV GP (Bundibugyo Ebola Virus Envelope Glycoprotein (BEBOV GP))

Type de proteíne: Recombinant

Attributs du protein: AA 33-304

Origine: Ebola Virus

Source: HEK-293 Cells

Purification/Conjugué: Cette BEBOV GP protéine est marqué à la His tag.

Fonction: Recombinant Ebolavirus (subtype Bundibugyo,strain Uganda 2007) Envelope Glycoprotein 1 (GP1) protein produced in HEK293 cells. Protein contains a C-terminal 6x His-tag

Specificité: Ebola virus envelope glycoprotein (GP1) is derived from the GP1 sequence (Accession # ACI28624), expressing Ile33 – Gln304.This Ebola virus envelope glycoprotein (GP1) is fused with a polyhistidine tag at the C-terminus, and has a calculated MW of 31.8 kDa. The protein is expressed in HEK293 cells.

Attributs du produit: Ebola Virus Envelope Glycoprotein (GP1) (Bundibugyo)

Pureté: >95 %

Information d'application

Commentaires:

This Ebola virus envelope glycoprotein (GP1) is derived from the GP1 sequence (Accession # ACI28624), expressing Ile33 – Gln304.This Ebola virus envelope glycoprotein (GP1) is fused with a polyhistidine tag at the C-terminus, and has a calculated MW of 31.8 kDa. The protein is expressed in HEK293 cells. DTT-reduced Protein migrates as 40-60 kDa in SDS-PAGE.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: PBS pH 7.4

Stock: 4 °C

Stockage commentaire: 4°C

Détail du antigène

Antigène: BEBOV GP (Bundibugyo Ebola Virus Envelope Glycoprotein (BEBOV GP))

Autre désignation: Ebola Envelope Glycoprotein (GP1) (Bundibugyo) (BEBOV GP Produits)

Classe de substances: Viral Protein

Sujet: Ebola virus envelope glycoprotein is initially produced as a precursor known as pre-GP, which is cleaved by furin into two subunits, GP1 and GP2, which remain associated through a disulfide linkage between Cys53 of GP1 and Cys609 of GP2. This heterodimer assembles into a 450-kDa trimer at the surface of nascent virions. The virion-attached GP is critical in the EBOV life cycle, as it is solely responsible for attachment, fusion and entry of target cells. Moreover, GP is responsible for critical pathogenic differences among viral species.
Ebola hemorrhagic fever (EHF) is a severe disease caused by several species of Ebolavirus (EBOV), in the family Filoviridae. Prior to 2007, four species of EBOV had been identified, with two (Zaire ebolavirus andSudan ebolavirus) having caused significant disease outbreaks in humans. Outbreaks of EHF are associated with person-to-person transmission after the virus is introduced into humans from a zoonotic reservoir. During outbreaks the virus is commonly transmitted through direct contact with infected persons or their bodily fluids. The onset of EHF is associated with nonspecific signs and symptoms, including fever, myalgias, headache, abdominal pain, nausea, vomiting, and diarrhoea. In the later stages of disease, overt hemorrhage has been reported in up to 50% of cases.
The presence of a fifth EBOV virus species,Bundibugyo ebolavirus (BEBOV) was identified after an outbreak of EHF in the Bundibugyo District of western Uganda in 2007.

UniProt: ACI28624